These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 10332695

  • 1. Metformin added to insulin therapy in poorly controlled type 2 diabetes.
    Hirsch IB.
    Diabetes Care; 1999 May; 22(5):854. PubMed ID: 10332695
    [No Abstract] [Full Text] [Related]

  • 2. Metformin useful in combination with exogenous insulin.
    Hanuschak LN.
    Diabetes Care; 1996 Jun; 19(6):671-2. PubMed ID: 8725873
    [No Abstract] [Full Text] [Related]

  • 3. Diabetes: insulin plus metformin for T2DM--are there benefits?
    Bailey CJ.
    Nat Rev Endocrinol; 2012 Jun 26; 8(8):449-50. PubMed ID: 22733270
    [No Abstract] [Full Text] [Related]

  • 4. [New data on hypoglycemia risk and beta cell function].
    MMW Fortschr Med; 2007 Nov 01; 149(44):57. PubMed ID: 18078171
    [No Abstract] [Full Text] [Related]

  • 5. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Avilés-Santa L, Sinding J, Raskin P.
    Ann Intern Med; 1999 Aug 03; 131(3):182-8. PubMed ID: 10428734
    [Abstract] [Full Text] [Related]

  • 6. Insulin as initial therapy for type 2 diabetes is not in the patient's best interest.
    Bell DS.
    Endocr Pract; 2004 Aug 03; 10(3):208-12. PubMed ID: 15310539
    [No Abstract] [Full Text] [Related]

  • 7. Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
    Vos RC, Rutten GEHM.
    JAMA; 2017 Oct 17; 318(15):1489-1490. PubMed ID: 29049639
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.
    Fritsche A, Schmülling RM, Häring HU, Stumvoll M.
    Acta Diabetol; 2000 Mar 17; 37(1):13-8. PubMed ID: 10928231
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Eff ectiveness of Teneligliptin as an Add-on in T2DM Patients not Controlled on Metformin and Glimepiride.
    Kashiv P, Kumar J.
    J Assoc Physicians India; 2020 Jan 17; 68(1):51. PubMed ID: 31979567
    [No Abstract] [Full Text] [Related]

  • 17. How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?
    Bell DS, Ovalle F.
    Endocr Pract; 2000 Jan 17; 6(4):293-5. PubMed ID: 11242605
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Benefits of metformin add-on insulin therapy (MAIT) for HbA1c and lipid profile in adolescents with type 1 diabetes mellitus: preliminary report from a double-blinded, placebo-controlled, randomized clinical trial.
    Sheikhy A, Eydian Z, Fallahzadeh A, Shakiba M, Hajipour M, Alaei M, Mosallanejad A, Saneifard H.
    J Pediatr Endocrinol Metab; 2022 Apr 26; 35(4):505-510. PubMed ID: 35249270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.